What does this video actually claim?
This Instagram post appears to be completely unrelated to testosterone replacement therapy, despite being tagged in the TRT category. The caption describes the plot of "Leyla ile Mecnun," a Turkish TV series about two babies born on the same day who become betrothed.
The post talks about characters named after legendary lovers, played by Ali Atay, in a show that ran from 2011-2023. There's literally no mention of hormones, testosterone, hypogonadism, or any medical topics whatsoever.
This looks like either a major categorization error or someone trying to game the algorithm by posting entertainment content in a medical category.
Does this connect to TRT science somehow?
No, it doesn't connect to testosterone replacement therapy research in any meaningful way. The TRAVERSE trial (Lincoff et al., NEJM, 2023) studied cardiovascular safety in 5,246 men with hypogonadism, but that's completely irrelevant here.
TRT typically involves testosterone cypionate or enanthate injections, topical gels, or pellet implants for men with clinically low testosterone (usually below 300 ng/dL). The Treatment Guidelines from the Endocrine Society recommend starting doses of 75-100mg weekly for injectable testosterone.
None of this has anything to do with Turkish romantic comedies or childhood betrothal stories.
What's actually wrong with this post?
Everything, from a medical information standpoint. This isn't a TRT-related post at all. It's entertainment content that somehow ended up categorized under testosterone replacement therapy.
If you're looking for actual TRT information, you'd want to know about things like the TTriUS registry data showing average testosterone increases from 243 ng/dL to 498 ng/dL with treatment. Or the fact that testosterone gels like AndroGel come in 1.62% concentrations with starting doses of 40.5mg daily.
Instead, we get plot summaries about fictional characters. This is either a mistake or deliberately misleading categorization.
What should you actually know about TRT?
Real testosterone replacement therapy is for men diagnosed with hypogonadism through blood tests showing consistently low testosterone levels. The American Urological Association guidelines require two separate morning testosterone measurements below the normal range.
Common TRT options include testosterone cypionate injections (100-200mg every 1-2 weeks), daily gels, or subcutaneous pellets lasting 3-6 months. The RHYME study (Grober et al., 2019) found that 68% of men preferred injections over gels for convenience and cost.
Side effects can include increased red blood cell count, acne, and potential cardiovascular risks, which is why the TRAVERSE trial was specifically designed to study heart safety. Regular monitoring includes testosterone levels, hematocrit, and PSA testing every 3-6 months.